A comparative analysis of the results from 4 trials of β-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS

This publication has 28 references indexed in Scilit:

• The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure
  Published by Elsevier ,2010
• Effects of Sustained-Release Moxonidine, an Imidazoline Agonist, on Plasma Norepinephrine in Patients With Chronic Heart Failure
  Circulation, 2002
• Heart failure 99 — the Moxcon story
  International Journal of Cardiology, 1999
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
  The Lancet, 1999
• Racial differences in the frequencies of cardiac ?1-adrenergic receptor polymorphisms: Analysis of c145A>G and c1165G>C
  Human Mutation, 1999
• The role of third-generation beta-blocking agents in chronic heart failure
  Clinical Cardiology, 1998
• Evaluation of Intrinsic Sympathomimetic Activity of Bucindolol and Carvedilol in Rat Heart
  Pharmacology, 1998
• Rationale, Design, and Organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF)
  The American Journal of Cardiology, 1997
• Racial Differences in β-Adrenoceptor-Mediated Responsiveness
  Journal of Cardiovascular Pharmacology, 1995
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958